WEILL MEDICAL COLL OF CORNELL UNIV
Targeting drivers of tumor heterogeneity to block the progression to neuroendocrine prostate cancer
Targeting drivers of tumor heterogeneity to block the progression to neuroendocrine prostate cancer is a funding opportunity from WEILL MEDICAL COLL OF CORNELL UNIV, up to 196745, closing June 30, 2027.
Jun 30, 2027
(334d left)Overview
PROJECT SUMMARY/ABSTRACT Despite advances in the development of highly effective androgen receptor (AR)-directed therapies for the treatment of men with advanced prostate cancer, acquired resistance ultimately ensues. Lineage plasticity has been proposed as one mechanism of therapeutic resistance whereby patients with…